168 related articles for article (PubMed ID: 11242180)
1. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients.
Millon L; Drobacheff C; Piarroux R; Monod M; Reboux G; Laurent R; Meillet D
J Acquir Immune Defic Syndr; 2001 Feb; 26(2):137-44. PubMed ID: 11242180
[TBL] [Abstract][Full Text] [Related]
2. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis.
Drobacheff C; Millon L; Monod M; Piarroux R; Robinet E; Laurent R; Meillet D
Clin Chem Lab Med; 2001 Jun; 39(6):519-26. PubMed ID: 11506465
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis.
Wozniak KL; Leigh JE; Hager S; Swoboda RK; Fidel PL
J Infect Dis; 2002 May; 185(9):1269-76. PubMed ID: 12001044
[TBL] [Abstract][Full Text] [Related]
4. Immunity to Candida.
Fidel PL
Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
[TBL] [Abstract][Full Text] [Related]
5. Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.
Vilanova M; Teixeira L; Caramalho I; Torrado E; Marques A; Madureira P; Ribeiro A; Ferreira P; Gama M; Demengeot J
Immunology; 2004 Mar; 111(3):334-42. PubMed ID: 15009435
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS.
Coogan MM; Sweet SP; Challacombe SJ
Infect Immun; 1994 Mar; 62(3):892-6. PubMed ID: 8112860
[TBL] [Abstract][Full Text] [Related]
7. Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.
Fidel PL
Adv Dent Res; 2006 Apr; 19(1):80-4. PubMed ID: 16672555
[TBL] [Abstract][Full Text] [Related]
8. Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects.
Belazi M; Fleva A; Drakoulakos D; Panayiotidou D
Int J STD AIDS; 2002 Jun; 13(6):373-7. PubMed ID: 12015010
[TBL] [Abstract][Full Text] [Related]
9. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
[TBL] [Abstract][Full Text] [Related]
10. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.
Chattopadhyay A; Gray LR; Patton LL; Caplan DJ; Slade GD; Tien HC; Shugars DC
Infect Immun; 2004 Apr; 72(4):1956-63. PubMed ID: 15039315
[TBL] [Abstract][Full Text] [Related]
11. Mucosal IgA Prevents Commensal
Millet N; Solis NV; Swidergall M
Front Immunol; 2020; 11():555363. PubMed ID: 33193324
[TBL] [Abstract][Full Text] [Related]
12. Correlation between CD4 count and intensity of Candida colonization in the oropharynx of HIV-infected/ AIDS patient.
Bandar IN; Widodo D; Djauzi S; Muthalib A; Soegondo S; Wahyuningsih R
Acta Med Indones; 2006; 38(3):119-25. PubMed ID: 16953027
[TBL] [Abstract][Full Text] [Related]
13. Novel Aggregation Properties of Candida albicans Secreted Aspartyl Proteinase Sap6 Mediate Virulence in Oral Candidiasis.
Kumar R; Saraswat D; Tati S; Edgerton M
Infect Immun; 2015 Jul; 83(7):2614-26. PubMed ID: 25870228
[TBL] [Abstract][Full Text] [Related]
14. Nonspecific secretory immunity in HIV-infected patients with oral candidiasis.
Bard E; Laibe S; Clair S; Biichlé S; Millon L; Drobacheff C; Bettinger D; Seillès E; Meillet D
J Acquir Immune Defic Syndr; 2002 Nov; 31(3):276-84. PubMed ID: 12439202
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin A1 and A2 subclass of salivary antibodies to Candida albicans in patients with oral candidosis.
Jeganathan S; Ufomata D; Hobkirk JA; Ivanyi L
Clin Exp Immunol; 1987 Nov; 70(2):316-21. PubMed ID: 3322616
[TBL] [Abstract][Full Text] [Related]
16. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.
Leigh JE; Steele C; Wormley FL; Luo W; Clark RA; Gallaher W; Fidel PL
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):373-80. PubMed ID: 9833746
[TBL] [Abstract][Full Text] [Related]
17. Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders.
Cassone A; Cauda R
AIDS; 2012 Jul; 26(12):1457-72. PubMed ID: 22472853
[TBL] [Abstract][Full Text] [Related]
18. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis.
Naglik JR; Newport G; White TC; Fernandes-Naglik LL; Greenspan JS; Greenspan D; Sweet SP; Challacombe SJ; Agabian N
Infect Immun; 1999 May; 67(5):2482-90. PubMed ID: 10225911
[TBL] [Abstract][Full Text] [Related]
19. Oropharyngeal Candida colonization in human immunodeficiency virus infected patients.
Li X; Lei L; Tan D; Jiang L; Zeng X; Dan H; Liao G; Chen Q
APMIS; 2013 May; 121(5):375-402. PubMed ID: 23030258
[TBL] [Abstract][Full Text] [Related]
20. Serum and saliva antibodies do not inhibit Candida albicans Sap2 proteinase activity using a BSA hydrolysis assay.
Naglik JR; Scott J; Rahman D; Mistry M; Challacombe SJ
Med Mycol; 2005 Feb; 43(1):73-7. PubMed ID: 15712610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
